Papilledema: Clinical Trials

28 trials for Papilledema, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed, 10 unknown, 2 recruiting, 2 terminated. 6 Phase 1, 5 Not applicable, 4 Phase 2, 3 Phase 4, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 16Completed 2, Terminated 2, Recruiting 1, Unknown 1
Not applicable5Completed 2, Unknown 2, Recruiting 1
Phase 24Completed 3, Terminated 1
Phase 43Unknown 2, Completed 1
Phase 32Completed 2
Early Phase 11Unknown 1

Follow Papilledema: new trials by email Literature Review of Papilledema trials Research Report on Papilledema

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Suprachoroidal Injection of Triamcinolone Acetonide in Resistant Diabetic Macular Edema, CRVO, Pseudophakic Cystoid Macular Edema and Diabetic Macular Edema Following Pars Plana Vitrectomy
Triamcinolone Acetonide 40Mg/Ml Inj,Susp_#1 - Retinal Edema
Early Phase 1UnknownTanta University1002024-12-012024-03-05
Optic Nerve Sheath Diameter in Hypertensive Emergency
Optic Nerve Sheath Diameter - Hypertensive Emergency, Papilledema
Not yet recruitingLeiden University Medical Center3752024-11-012024-10-09
Building Research With Artificial Intelligence in Neuro-Ophthalmology
Deep learning algorithm applied on retrospectively collected color fundus photographs - Optic Neuropathy, Optic Neuropathy, Ischemic
CompletedFondation Ophtalmologique Adolphe de Rothschild6932023-10-012025-09-08
IIH Intervention: A Clinical Trial Comparing 2 Treatments (Shunts and Stents) Evaluation Of Clinical Effectiveness And Cost Effectiveness
CSF shunt, DVSS - IIH - Idiopathic Intracranial Hypertension
Not applicableRecruitingUniversity of Birmingham802023-07-182026-02-27
MR Lymphatic Imaging in Idiopathic Intracranial Hypertention
3T MRI with Gadobutrol injection - Idiopathic Intracranial Hypertension
Not applicableCompletedInstitut National de la Santé Et de la Recherche Médicale, France402023-03-102026-10-08
The Effect of an Anti-obesity Drug, Semaglutide, as Treatment in New-onset Idiopathic Intracranial Hypertension (IIH) Compared to Standard Weight Management (Dietician) With Regards to Change in Weight and Intracranial Pressure
Semaglutide, Very Low Calorie Diet, Dietician counselling - Idiopathic Intracranial Hypertension, Intracranial Pressure
Phase 4CompletedRigmor Højland Jensen382022-09-022026-02-27
B-Complex: A Nutraceutical SANS Countermeasure
Vitamin B-Complex Supplement - Optic Disc Edema, Endothelial Dysfunction
Phase 1RecruitingNational Aeronautics and Space Administration (NASA)162022-08-012025-05-22
High Resolution Optical Coherence Tomography
High-resolution optical coherence tomography (High-Res-OCT), Standard spectral domain OCT (SD-OCT) - Retinal Disease, Retinal Detachment
UnknownInsel Gruppe AG, University Hospital Bern5502021-11-302022-11-29
VEHICLE Registry: Venous Stenting for IIH in the MENA Region
Venous Sinus Stenting Procedure - Idiopathic Intracranial Hypertension (IIH)
UnknownMiddle East North Africa Stroke and Interventional Neurotherapies Organization1502021-08-112024-11-18
Assessing the Efficacy and Safety fo DEXTENZA, Sustained Release Dexamethasone 0.4 mg Insert(s) for the Treatment of Pain, Inflammation, and Cystoid Macular Edema Following 27 Gauge Vitrectomy With Internal Limiting Membrane Peel for the Treatment of Retinal Edema Associated With Macular Pucker.
Dexamethasone Intracanalicular Insert, 0.4 mg, Prednisone acetate 1% - Vitrectomy, Macular Pucker
Phase 4UnknownKovach Eye Institute602021-04-272023-06-29
Determination of Normal Measures of Optic Nerve Sheath Diameter in Children
Ultrasonic Measurement will be taken from optic nerve sheat diameter and compared-classified. - Optic Papilla Edema
CompletedCukurova University2002020-06-152025-02-13
Validation of Non-Invasive Intracranial Pressure (ICP) Monitoring Device
Non-invasive ICP measurement - Intracranial Hypertension, Abnormality of Intracranial Pressure
UnknownBoston Neurosciences802019-03-012019-03-07
Endovascular Stenting Treatment for Patients With Internal Jugular Vein Stenosis
Venous stenting for internal jugular vein stenosis, One-month routine medical treatment followed by venous stenting for internal jugular vein stenosis - Stent Stenosis, Intracranial Hypertension
Phase 1UnknownCapital Medical University602018-01-012017-12-14
Cerebral Venous Sinus Thrombosis: Re-exploration of Clinical Assessment Scales
Cerebral Venous Sinus Thrombosis, CSF Pressure Increased
UnknownCapital Medical University1002017-06-012018-02-05
Ocular Point of Care Ultrasound (POCUS) to Detect Optic Disc Swelling in Comparison to Ophthalmologic Examination
Point of care ocular ultrasound - Papilledema Associated With Increased Intracranial Pressure
Not applicableUnknownmichal roll3002017-01-012016-12-14
aICP in Glaucoma and Papilledema
Non-invasive ICP measurement (Vittamed 305) - Open-angle Glaucoma, Papilledema
Not applicableUnknownKantonsspital Aarau602015-04-012015-04-08
Safety and Effectiveness of 11b-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) to Treat Idiopathic Intracranial Hypertension.
AZD4017, Placebo - Idiopathic Intracranial Hypertension
Phase 2CompletedUniversity of Birmingham312014-04-252021-10-27
Antiacne Medications Pseudotumor Cerebri
Retinal nerve fibre layer measurement - Optic Disc Swelling
Phase 4UnknownUniversity of Zurich3102014-04-012014-05-29
Ocular Manifestations in Rheumatic Diseases
No intervention used - Uveitis, Conjunctivitis
CompletedLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's50002013-05-012022-04-12
Prolensa (Bromfenac) 0.07% QD vs. Ilevro (Nepafenac) 0.3% QD for Treatment of Ocular Inflammation Post Cataract Surgery
Prolensa (bromfenac 0.07%), Ilevro (nepafenac 0.3%) - Cataract, Retinal Edema
Not applicableCompletedMelissa Toyos502013-04-012018-11-14

Showing 20 of 28. Sign in to see all of them.

Narrower conditions

Pseudotumor Cerebri (8)  ·  Headache (4)  ·  Intracranial Hypertension (4)  ·  Macular Edema (4)  ·  Obesity (3)  ·  Tinnitus (3)  ·  Uveitis (3)  ·  Vision Disorders (3)  ·  Blindness (2)  ·  Epiretinal Membrane (2)  ·  Glaucoma (2)  ·  Idiopathic Juxtafoveal Retinal Telangiectasia (2)  ·  Optic Nerve Diseases (2)  ·  Optic Neuritis (2)

Broader conditions

Cranial Nerve Diseases (28)  ·  Eye Diseases (28)  ·  Nervous System Diseases (28)  ·  Optic Nerve Diseases (26)  ·  Brain Diseases (12)  ·  Central Nervous System Diseases (12)  ·  Pathological Conditions, Signs and Symptoms (11)  ·  Cardiovascular Diseases (7)  ·  Intracranial Hypertension (7)  ·  Signs and Symptoms (7)  ·  Vascular Diseases (7)  ·  Neurologic Manifestations (6)  ·  Pathologic Processes (5)  ·  Retinal Diseases (5)  ·  Sensation Disorders (5)

Interventions

Ranibizumab (2)  ·  2-(1-(5-(cyclohexylcarbamoyl)-6-propylsulfanylpyridin-2-yl)-3-piperidyl)acetic acid (1)  ·  Acetaminophen (1)  ·  Acetazolamide (1)  ·  Aspirin (1)  ·  Calcium Dobesilate (1)  ·  Codeine (1)  ·  Dexamethasone (1)  ·  Ibuprofen (1)  ·  Interleukin 1 Receptor Antagonist Protein (1)  ·  Naproxen (1)  ·  Triamcinolone Acetonide (1)  ·  bromfenac (1)  ·  butalbital (1)  ·  nepafenac (1)

Sponsors

Capital Medical University (2)  ·  National Eye Institute (NEI) (2)  ·  University of Birmingham (2)  ·  Boston Neurosciences (1)  ·  Cukurova University (1)  ·  Fondation Ophtalmologique Adolphe de Rothschild (1)  ·  Insel Gruppe AG, University Hospital Bern (1)  ·  Institut National de la Santé Et de la Recherche Médicale, France (1)  ·  Kantonsspital Aarau (1)  ·  Kovach Eye Institute (1)  ·  Leiden University Medical Center (1)  ·  London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (1)  ·  Melissa Toyos (1)  ·  Middle East North Africa Stroke and Interventional Neurotherapies Organization (1)  ·  National Aeronautics and Space Administration (NASA) (1)

Countries

United States (10)  ·  Switzerland (3)  ·  Egypt (2)  ·  France (2)  ·  United Kingdom (2)  ·  Canada (1)  ·  China (1)  ·  Denmark (1)  ·  Germany (1)  ·  Iran (1)  ·  Saudi Arabia (1)  ·  Turkey (Türkiye) (1)

Top investigators

Alexandra Sinclair, MbChb PhD (1)  ·  Amin E Nawar, Lecturer (1)  ·  Arnd Heiligenhaus, MD (1)  ·  Behrouz Nikbin, MD (1)  ·  Fereydoun Davatchi, MD (1)  ·  Hanspeter Killer, MD (1)  ·  Hormoz Shams, MD (1)  ·  Janet Pope, MD (1)  ·  John Khadem, MD (1)  ·  Klara Landau, Prof MD (1)  ·  Melissa Toyos, MD (1)  ·  Michael Wall, MD (1)  ·  Oussama Habra, MD (1)  ·  Ran Meng, MD, PhD (1)  ·  Raphaela T Goldbach-Mansky, M.D. (1)

Results publications

PMID 16899778, PMID 22294344, PMID 23773637, PMID 24756302, PMID 24756514, PMID 24781936, PMID 25223501, PMID 25370510, PMID 25370513, PMID 26024112, PMID 26335066, PMID 26582161, PMID 26618282, PMID 26778344, PMID 26934136, PMID 27143789, PMID 27694262, PMID 28118536, PMID 28130349, PMID 28492874, PMID 28923789, PMID 30868419, PMID 33098644, PMID 33281736, PMID 35469288, PMID 36240084, PMID 36438589, PMID 37740611, PMID 40576025, PMID 40604486, PMID 42487032

NIH funding

U10EY017281 (1), U10EY017387 (1), ZIAAR041138-08 (1)